Symphogen raised €20M in a Series C round in Nov 2004. The company is based in Ballerup, Denmark. Investors in the round: Essex Woodlands Health Ventures, Novo A, S. Data as of 7 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
